| Identification | More | [Name]
L-Carnitine orotate | [CAS]
160468-17-7 | [Synonyms]
(2r)-3-carboxy-2-hydroxy-n,n,n-trimethyl-1-propanaminium 1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic acid salt
L-CARNITINE OROTATE
(r)-(3-carboxy-2-hydroxypropyl)-trimethyl ammonium orotate
L-Carnitine orotic acid salt
Dl-/L-Carnitine Orotate
(2R)-3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium 1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic acid salt | [EINECS(EC#)]
605-211-7 | [Molecular Formula]
C12H17N3O6 | [MDL Number]
MFCD07367788 | [Molecular Weight]
299.28 | [MOL File]
160468-17-7.mol |
| Hazard Information | Back Directory | [Uses]
L-Carnitine Orotate decreases seizure frequency in epileptic patients. Treats dermatosis such as ichthyosis and psoriasis. | [Synthesis]
(1) 156g (1mol) of whey acid was dissolved in 2000mL of water, warmed up to 80℃, and then added 1.2mol of ammonia with a mass percentage concentration of 25% with stirring, and the reaction time was 1.5 hours at the above temperature, after the reactio |
|
|